Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | EYA2 | O00167 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15284072 | 0.80 | FFAR3 (0.36) | TDP1EYA2APPACETSHR | |
| SCHEMBL3743471 | 0.76 | TDP1 (0.33) | TDP1EYA2APPACETSHR | |
| SCHEMBL8948418 | 0.76 | CA2 (0.41) | KDM4ELMNAALOX15 | |
| SCHEMBL867976 | 0.76 | TDP1 (0.41) | TDP1EYA2APPACETSHR | |
| Hydrochloric Acid SCHEMBL5577032 | 0.74 | TDP1 (0.39) | TDP1EYA2APPACETSHR | |
| SCHEMBL186528 | 0.74 | TDP1 (0.39) | TDP1EYA2APPACETSHR | |
| SCHEMBL8948341 | 0.74 | TDP1 (0.39) | TDP1EYA2APPACETSHR | |
| SCHEMBL30786609 | 0.73 | FOLH1 (0.41) | TDP1TSHRLMNABLMCYP1A2 | |
| SCHEMBL676800 | 0.72 | GABRP (0.42) | TDP1EYA2APPACEGABRP | |
| SCHEMBL3901854 | 0.72 | TDP1 (0.38) | TDP1EYA2APPACETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621735-A1 | PROTECTIVE SURFACE COATINGS FOR FLOW CELLS | Illumina, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| WO-2019058318-A1 | Formulations to administer SUMO2/3 | PLICO BIOTECH INC. (US) | 2019-03-28 | — | — | WO | claimed |
| EP-3411077-A1 | EFFICIENT PROCESS FOR PREPARING CELL-BINDING AGENT-CYTOTOXIC AGENT CONJUGATES | ImmunoGen, Inc. (US) | 2018-12-12 | — | — | EP | claimed |
| WO-2018208561-A1 | PROTECTIVE SURFACE COATINGS FOR FLOW CELLS | ILLUMINA, INC. (US) | 2018-11-15 | — | — | WO | claimed |
| WO-2017136623-A1 | EFFICIENT PROCESS FOR PREPARING CELL-BINDING AGENT-CYTOTOXIC AGENT CONJUGATES | IMMUNOGEN, INC. (US) | 2017-08-10 | — | — | WO | claimed |
| US-5574050-A | Hydroxyl ions as unique therapeutic agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-11-12 | — | — | US | claimed |
| EP-0725636-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1996-08-14 | — | — | EP | claimed |
| US-5514808-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions | FHJ SCIENTIFIC, INC (US) | 1996-05-07 | — | — | US | claimed |
| WO-1995010272-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1995-04-20 | — | — | WO | claimed |
| EP-0158556-B1 | PROCESS FOR THE PREPARATION OF HYDROXYALKYLAMINOACETIC ACIDS | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1987-07-01 | — | — | EP | claimed |
| EP-4221680-A1 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2023-08-09 | — | — | EP | disclosed |
| EP-4126069-A1 | RNA PARTICLES COMPRISING POLYSARCOSINE | BioNTech SE (DE) | 2023-02-08 | — | — | EP | disclosed |
| US-20220287949-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | BAMBU VAULT LLC (US) | 2022-09-15 | — | — | US | disclosed |
| EP-3997140-A1 | TWO-COMPONENT SYSTEM FOR THE IN SITU PREPARATION OF AN ARTIFICIAL CARTILAGE | Heraeus Medical GmbH (DE) | 2022-05-18 | — | — | EP | disclosed |
| EP-3993835-A1 | RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2022-05-11 | — | — | EP | disclosed |
| US-5574050-A | Hydroxyl ions as unique therapeutic agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0725636-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1996-08-14 | — | — | EP | disclosed |
| US-5514808-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions | FHJ SCIENTIFIC, INC (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1995010272-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1995-04-20 | — | — | WO | disclosed |
| EP-0158556-A1 | Process for the preparation of hydroxyalkylaminoacetic acids | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1985-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220287949-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | MPO, CUTA, LPO | TDP1 2693/4885EYA2 1916/4885APP 2377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.